Tenax Therapeutics, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
Asset Breakdown FY2024
Total Assets: $96.7M
Liabilities Breakdown FY2024
Total Liabilities: $4.7M
Asset Breakdown
Total Assets: $96.7M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $94.9M | 98.2% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $0 | 0.0% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $1.8M | 1.8% |
Liabilities Breakdown
Total Liabilities: $4.7M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $3.2M | 67.3% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $1.5M | 32.7% |